Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Htmms drug linked to rare and fatal nerve infection ms drug linked to

MagazineJune 2005 (Vol. 16 Issue 3)Htmms drug linked to rare and fatal nerve infection ms drug linked to

Biogen Idec is suspending the marketing of its multiple-sclerosis drug Tysabri (natalizumab), following one confirmed and fatal case, and another confirmed case, of progressive multifocal leukoencephalopathy (PML) in patients taking the monoclonal-antibody drug

Biogen Idec is suspending the marketing of its multiple-sclerosis drug Tysabri (natalizumab), following one confirmed and fatal case, and another confirmed case, of progressive multifocal leukoencephalopathy (PML) in patients taking the monoclonal-antibody drug. The relationship between Tysabri and PML has yet to be confirmed. However, given the aggressive nature of PML (death usually occurs one to four months after onset), Biogen has also stopped all clinical trials using Tysabri.
PML is a rare viral disorder of the brain and nervous system that primarily affects people with suppressed immune function such as patients with cancers like leukaemia or lymphoma, or victims of AIDS (acquired immunodeficiency syndrome). The infection is characterised by destruction of the fatty myelin sheath that insulates the nerve fibres of the brain. Symptoms of PML include mental deterioration, vision loss, speech disturbances, ataxia (inability to coordinate physical movements), paralysis and, ultimately, coma. In rare cases, seizures may also occur.
There is currently no effective treatment or possible cure for the disorder (www.fda.gov/cder/drug/advisory/natalizumab.htm).


For 'processed', read 'adulterated'

And surviving your stay there

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved